Acutil® in Mild Cognitive Impairment or Early Dementia: An Exploratory Observational Pilot Study

Author(s): Michael Rainer, Hermann A.M. Mucke*

Journal Name: Current Psychiatry Research and Reviews
Formerly Current Psychiatry Reviews

Volume 17 , Issue 1 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: With no approved treatment for mild cognitive impairment (MCI), attention increasingly turns to qualified food supplements.

Objective: To conduct a 12-month rater-blinded exploratory outpatient trial with Acutil®, a supplement consisting of ω-3 polyunsaturated fatty acids, Ginkgo biloba extract, and vitamins, in 50 persons with amnestic MCI or mild to moderate Alzheimer or mixed-type dementia.

Methods: The used cognitive tools were the Alzheimer's Disease Assessment Scale- Cognitive Subscale (ADAS-Cog), the Mini-Mental State Exam (MMSE), and Controlled Oral Word Association Test (COWAT). Patients were randomized in the ratio of 40:10 to additional Acutil® or no additional supplementation; all continued on their existing medications during the entire study.

Results: Only the COWAT produced a clear positive signal in the Acutil® group between individual baseline and study endpoint, but the between-group comparison was not statistically significant. The MMSE score remained stable in the Acutil® group while deteriorating in the control group; post hoc examination suggests that the Acutil® group might have contained responders. The ADAS-Cog and Clinical Dementia Rating (CDR) scores showed marginal deterioration in both groups.

Conclusion: We tentatively interpret our results as potentially indicating positive effects of Acutil® on verbal fluency and some aspects of executive function, with an onset after 6 months of continuous treatment. However, much larger and double-blinded studies will be required to make firm statements.

Keywords: Alzheimer disease, cognitive dysfunction, dietary supplements, mental status, dementia tests, Ginkgo biloba.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 21 April, 2021
Page: [26 - 32]
Pages: 7
DOI: 10.2174/2666082217666210421113710
Price: $65

Article Metrics

PDF: 374